You are here:
mesalazine (Asacol)
Advice
Following an abbreviated submission
Mesalazine 800 mg modified release tablet (Asacol) is accepted for use in NHS Scotland for the treatment of mild acute exacerbations of ulcerative colitis.
At the recommended dose of up to 2.4g daily, the 800 mg strength allows halving of the pill burden compared with the 400 mg formulation at no extra cost.
Drug Details
| Drug Name: | mesalazine (Asacol) |
|---|---|
| SMC Drug ID: | 223/05 |
| Manufacturer: | Procter and Gamble |
| Indication: | Mild acute exacerbations for ulcerative colitis |
| BNF Category: | |
| Sub Category: | 1.5 Chronic bowel disorders |
| Submission Type: | Abbreviated Submission |
| Status: | Accepted |
| Date Advice Published: | 11 February 2008 |